Literature DB >> 6549614

Enzymatic inactivation of 6-keto-prostaglandin E1 in vitro: comparison with prostaglandin E1.

C N Berry, J R Hoult, R J Griffiths, P K Moore.   

Abstract

The inactivation of 6-keto PGE1, a biologically active and stable metabolite of prostacyclin, was studied in 100,000 g cytosolic supernatants by bioassay on rat stomach strip (contraction) and human platelets (inhibition of ADP-induced aggregation). PGE1 was used as a reference compound. Both PGs were inactivated in supernatants from colon, kidney and liver of rat, rabbit and guinea-pig. Inactivation was time- and NAD+ -dependent and was generally greater for PGE1 than 6-keto-PGE1. The enzyme responsible for 6-keto-PGE1 inactivation in cytosolic supernatants is distinct from prostaglandin 15-hydroxydehydrogenase and 9-keto reductase, is not inhibitable by sulphasalazine-like drugs and its activity is recoverable after precipitation by ammonium sulphate. We conclude that 6-keto-PGE1 can be inactivated by enzymes with wide tissue distribution, but further studies are needed for identification of these novel enzymes and the products formed as well as to assess their significance in the intact animal.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6549614     DOI: 10.1016/0006-2952(84)90181-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  1 in total

1.  Single-blind study of epoprostenol and 6-keto-prostaglandin E1 in man: effects of platelet aggregation and plasma renin.

Authors:  I Miyamori; T Morise; S Yasuhara; Y Takeda; H Koshida; R Takeda
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.